Roginolisib (hemifumarate)
Roginolisib (MSC2360844) hemifumarate is a potent, orally active and selective PI3Kδ inhibitor, with an IC50 of 145 nM. Roginolisib hemifumarate shows highly selective against a panel of 278 additional kinases[1].
Product Specifications
CAS Number
[1621688-31-0]
Product Name Alternative
MSC2360844 (hemifumarate) ; IOA-244 (hemifumarate)
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/roginolisib-hemifumarate.html
Concentration
10mM
Purity
99.80
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=NN(C2=CC=C(CN3CCOCC3)C=C2)C(C4=CC=CC(F)=C45)=C1CS5(=O)=O)N6CCOCC6.OC(/C=C/C(O)=O)=O
Molecular Formula
C26H27FN4O5S.1/2C4H4O4
Molecular Weight
584.62
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
PI3Kδ
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Human Mediator Of RNA Polymerase II Transcription Subunit 14 (MED14) ELISA Kit
Human Mediator Of RNA Polymerase II Transcription Subunit 14 (MED14) ELISA Kit
Human Mediator Of RNA Polymerase II Transcription Subunit 14 (MED14) ELISA Kit
Hepatitis B Surface Antigen, adw, ayw (HBsAg) (MaxLight 750) discontinued